Strukturen zur neurologischen Versorgung in Deutschland

Peter Berlit(Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie), Lars Timmermann(Philipps University of Marburg), Helge Topka(University of Tübingen), Susanne Knake(Paracelsus Elena Klinik Kassel), Stefan Schwab(Friedrich-Alexander-Universität Erlangen-Nürnberg), Joseph Claßen(University Hospital Leipzig), Martin Glas(Essen University Hospital), Darius G. Nabavi(Vivantes Klinikum), Julian Bösel(Heidelberg University)
DGNeurologie
August 15, 2023
10.1007/s42451-023-00580-w
Cited by 2

Related Papers

Action Plan for Stroke in Europe 2018–2030
|European Stroke Journal|2018|616
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
|The Lancet|2019|581
Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
|The Lancet|2019|524
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals
|Movement Disorders|2023|351
Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit
|Neurology|2011|350